Jorge Daniel Erusalimsky
7Patents
1h-index
5Co-inventors
40Inventor score
Filing activity: Jul 26, 2002 → Dec 22, 2015
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7071183B2 | Use of inhibitors of the renin-angiotensin system | Chemistry; Metallurgy | 1 | Expired |
| US8003679B2 | Use of inhibitors of the renin-angiotensin system | Chemistry; Metallurgy | 0 | Active |
| US7998953B2 | Use of inhibitors of the renin-angiotensin system | Chemistry; Metallurgy | 0 | Active |
| US8604070B2 | Use of inhibitors of the renin-angiotensin system | Chemistry; Metallurgy | 0 | Active |
| US11324746B2 | Use of anagrelide for treating cancer | Human Necessities | 0 | Active |
| US7022693B2 | Treatment of lipodystrophy | Human Necessities | 0 | Expired |
| US9017936B2 | Assays for agents affecting megakaryocyte development | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.